Season's Savings | ₹5/mo for 3 months
₹199/month after first 3 months. Renews automatically. Terms apply.
FDA Warns of Vision Loss From All GLP1 Drugs
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
FDA Warns of Vision Loss From All GLP1 Drugs
-
Narrated by:
-
Written by:
About this listen
On November 9, 2026 the FDA announced that Ozempic, Wegovy, Mounjaro & Zepbound must have warning labels that these GLP1 drugs can cause sudden, severe, irreversible vision loss or blindness from a condition called NAION. NAION is a disease where the optic nerve suddenly loses its blood supply - essentially a stroke of the optic nerve. Watch this interview with the world's leading expert on this condition, Harvard neuro-ophthalmologist, Joseph Rizzo, M.D. Dr. Rizzo described the first patients with this condition in a medical journal publication in July 2024. DoctorPodcasts interviewed him at that time and now has an update with Dr. Rizzo in view of the new FDA warning.
adbl_web_anon_alc_button_suppression_t1
No reviews yet